课题基金 / 基金详情

Tropism and pathogenesis of measles virus

Tropism and pathogenesis of measles virus
麻疹病毒的趋向性和发病机制
批准号:
13470064
负责人:
YANAGI Yusuke
金额:
$10.5万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

YANAGI Yusuke的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1. By titrating viruses on Vero and Vero/SLAM cells, we show that the great majority of measles viruses in measles patients use SLAM but not CD46 as a cellular receptor, thereby proving that SLAM is the principal receptor for measles virus.2.We show that although monocytes freshly isolated from peripheral blood mononuclear cells do not express SLAM, its expression is readily induced after stimulation with mitogens or even with measles virus particles. Furthermore, mature dendritic cells, but not immature dendritic cells, also express SLAM. These results indicate that MV infection of monocytes/macrophages and dendritic cells, like that of lymphocytes, is mediated by SLAM.3. We show that canine distemper virus and rinderpest virus respectively use canine and bovine SLAMs as cellular receptors.4. By using the recombinant measles virus expressing the green fluorescent protein, we show that wild-type measles virus strains can infect SLAM-negative cells with 2 to 3 logs lower efficiency than it does SLAM-positive cells, indicating the presence of SLAM- and CD46-independent measles virus infection.5. We show that the interaction of the measles virus H protein with SLAM results in its downregulation from the cell surface, suggesting its involvement in measles virus-induced immunosuppression.
期刊论文(60)
专著(0)
科研奖励(0)
会议论文
Tatsuo H, Yanagi Y: "The morbillivirus receptor SLAM (CD150)"Microbiology and Immunology. 46. 135-142 (2002)
Tatsuo H、Yanagi Y:“麻疹病毒受体 SLAM (CD150)”微生物学和免疫学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tatsuo H, Ono N, Yanagi Y: "Morbilliviruses Use Signaling Lymphocyte Activation Molecules (CD150) as Cellular Receptors"Journal of Virology. 75. 5842-5850 (2001)
Tatsuo H、Ono N、Yanagi Y:“麻疹病毒使用信号淋巴细胞激活分子 (CD150) 作为细胞受体”病毒学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Minagawa H, Tanaka K, Ono N, Tatsuo H, Yanagi Y: "Induction of the measles virus receptor SLAM (CD150) on monocytes"Journal of General Virology. 82. 2913-2917 (2001)
Minakawa H、Tanaka K、Ono N、Tatsuo H、Yanagi Y:“单核细胞上麻疹病毒受体 SLAM (CD150) 的诱导”普通病毒学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tatsuo H., Yanagi Y.: "The morbillivirus receptor SLAM (CD150)"Microbiol. Immunol.. 46. 135-142 (2002)
Tatsuo H.,Yanagi Y.:“麻疹病毒受体 SLAM (CD150)”微生物学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
24
    Mechanism of measles virus spread in the brain
    Development of new therapy for congenital metabolic disorders using functional three-dimensional liver structures constructed by stem cells from human exfoliated deciduous teeth
    • 批准号:
      24592696
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2012
    • 负责人:
      YANAGI Yusuke
    • 依托单位:
    Measles pathogenesis as studied using animal models
    • 批准号:
      21249032
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $29.62万
    • 财政年份:
      2009
    • 负责人:
      YANAGI Yusuke
    • 依托单位:
    Analysis of measles pathogenesis using the mouse model expressing measles virus receptor SLAM and recombinant viruses
    • 批准号:
      17209016
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $32.45万
    • 财政年份:
      2005
    • 负责人:
      YANAGI Yusuke
    • 依托单位:
    国内基金
    海外基金
    盐皮质激素受体抑制2型固有淋巴细胞活化加重心肌梗死后心室重构的作用机制
    • 批准号:
      82372202
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      侯旭敏
    • 依托单位:
    GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
    • 批准号:
      82371652
    • 项目类别:
      面上项目
    • 资助金额:
      45.00万元
    • 批准年份:
      2023
    • 负责人:
      刘开江
    • 依托单位:
    多囊卵巢综合征中甲酰肽受体2调控小胶质细胞代谢重编程导致GnRH神经元过度激活及HPO轴异常的病理机制研究
    • 批准号:
      82370797
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      陶弢
    • 依托单位:
    G蛋白偶联受体GPR110调控Lp-PLA2抑制非酒精性脂肪性肝炎的作用及机制研究
    • 批准号:
      82370865
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      黄哲
    • 依托单位: